DANIELLE FARRIOR: Open Payments
NPI 1285931816 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,844 in 106 payments from 15 companies in 2025. Trend: 2023 $1,584 · 2024 $2,058 · 2025 $1,844
Food & beverage: $1,682Education: $162
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $327 |
| Janssen Biotech, Inc. | 25 | $286 |
| Mallinckrodt Hospital Products Inc. | 9 | $230 |
| PFIZER INC. | 15 | $207 |
| UCB, Inc. | 7 | $205 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| Incyte Corporation | 6 | $129 |
| GENZYME CORPORATION | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $46 |
Products named: TREMFYA, DUPIXENT, ACTHAR, CIBINQO, Bimzelx, SKYRIZI, RINVOQ, OPZELURA.
Industry payments across FL — which companies pay providers there.
